Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K241923
    Date Cleared
    2024-12-06

    (158 days)

    Product Code
    Regulation Number
    892.2080
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    EFAI Neurosuite CT Midline Shift Assessment System (MLS-CT-100)

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    EFAI NEUROSUITE CT MIDLINE SHIFT ASSESSMENT SYSTEM (EFAI MLSCT) is a software workflow tool designed to aid in prioritizing the clinical assessment of non-contrast head CT cases with features suggestive of midline shift (MLS) in individuals aged 18 years and above. EFAI MLSCT analyzes cases using deep learning algorithms to identify suspected MLS findings. It makes case-level output available to a PACS/workstation for worklist prioritization or triage.

    EFAI MLSCT is not intended to direct attention to specific portions of an image or to anomalies other than MLS. Its results are not intended to be used on a stand-alone basis for clinical decision-making nor is it intended to rule out MLS or otherwise preclude clinical assessment of CT studies.

    Device Description

    EFAI NEUROSUITE CT MIDLINE SHIFT ASSESSMENT SYSTEM (EFAI MLSCT) is a radiological computer-assisted triage and notification software system. The software uses deep learning techniques to automatically analyze non-contrast head CTs and alerts the PACS/RIS workstation once images with features suggestive of MLS are identified.

    Through the use of EFAI MLSCT, a radiologist is able to review studies with features suggestive of MLS earlier than in standard of care workflow.

    The device is intended to provide a passive notification through the PACS/workstation to the radiologists indicating the existence of a case that may potentially benefit from the prioritization. It does not mark, highlight, or direct users' attention to a specific location on the original non-contrast head CT. The device aims to aid in prioritization and triage of radiological medical images only.

    AI/ML Overview

    Here's an analysis of the acceptance criteria and study details for the EFAI Neurosuite CT Midline Shift Assessment System (MLS-CT-100), based on the provided text:


    Acceptance Criteria and Device Performance

    1. Table of Acceptance Criteria and Reported Device Performance

    MetricAcceptance Criteria (Lower Bound of 95% CI)Reported Device Performance (95% CI)
    Sensitivity> 0.80.961 (0.903-0.985)
    Specificity> 0.80.955 (0.916-0.973)
    AUROCNot explicitly stated (but reported)0.983 (0.967-0.996)
    Processing TimeSignificantly less than pre-specified goal62.04 seconds (60.65-63.44)

    2. Sample Size and Data Provenance

    • Test Set Sample Size: 300 cases (102 positive for MLS, 198 negative for MLS). Each case included only one CT study.
    • Data Provenance: Retrospective, consecutively collected from multiple clinical sites across the United States (U.S.). The U.S. cases were solely collected for this study.

    3. Number and Qualifications of Experts for Ground Truth (Test Set)

    • Number of Experts: Three (3)
    • Qualifications: U.S. board-certified radiologists.

    4. Adjudication Method (Test Set)

    • Adjudication Method: Majority agreement between the three experts established the reference standard (ground truth).

    5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

    • Was it done? No. The document describes a "standalone performance validation study" and mentions "Reader comparison analysis" for overall safety & effectiveness, but does not detail an MRMC comparative effectiveness study where human readers' performance with and without AI assistance was evaluated for an effect size. The study described focuses on the standalone performance of the AI.

    6. Standalone Performance Study

    • Was it done? Yes. The document explicitly states: "The observed results of the standalone performance validation study demonstrated that EFAI MLSCT by itself, in the absence of any interaction with a clinician, can provide case-level notifications with features suggestive of MLS with satisfactory results."

    7. Type of Ground Truth Used

    • Type of Ground Truth: Expert consensus (majority agreement of three U.S. board-certified radiologists).

    8. Sample Size for the Training Set

    • The document states that the "model development and validation utilized cases from Taiwan," but it does not specify the sample size for the training set. It only mentions that the U.S. validation cases were not used for model development or analytical validation testing.

    9. How the Ground Truth for the Training Set Was Established

    • The document indicates that the model was developed and validated using cases from Taiwan, but it does not describe how the ground truth for these training cases was established.
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1